• OUR DATA
  • BUY REPORTS & LISTS
  • OUR BLOG
 

Johnson & Johnson Revenue and Financial Data

It's difficult to get well without Johnson & Johnson (J&J). The diversified health care giant operates in three segments through more than 275 operating companies located in some 60 countries. Its Medical Devices and Diagnostics division offers surgical equipment, monitoring devices, orthopedic products, and contact lenses, among other things. J&J's Pharmaceuticals division makes drugs for an array of ailments, such as neurological conditions, blood disorders, autoimmune diseases, and pain. Top sellers are psoriasis drug Remicade and cancer medication Velcade. Its Consumer business makes over-the-counter drugs and products for baby, skin, and oral care, as well as first aid and nutritional uses.

Financials Information for Johnson & Johnson

Track this company’s financial condition.
View Company Report
Request Your Free Trial

  • Income Statement
  • Cash Flow
  • Balance Sheet
  • Credit Rating
Income Statement 2013 2012 2011 2010 2009
Revenue $71312.0 $67224.0 $65030.0 $61587.0 $61897.0
Gross Profit $48970.0 $45566.0 $44670.0 $42795.0 $43450.0
Operating Income $18377.0 $15869.0 $16153.0 $16527.0 $15590.0
Net Income $13831.0 $10853.0 $9672.0 $13334.0 $12266.0
Diluted EPS $4.81 $3.86 $3.49 $4.78 $4.4
Cash Flow (mil) 2013 2012 2011
Cash at the beginning of the year $14911.0 $24542.0 $19355.0
Net Operating Cash $17414.0 $15396.0 $14298.0
Net Investing Cash $-5103.0 $-4510.0 $-4612.0
Net Financing Cash $-6091.0 $-20562.0 $-4452.0
Net Change in Cash $6016.0 $-9631.0 $5187.0
Cash at end of the year $20927.0 $14911.0 $24542.0
Capital Expenditure $-3595.0 $-2934.0 $-2893.0
Assets (mil) 2013 2012 2011
Current Assets
Cash $20927.0 $14911.0 $24542.0
Net Receivables $11713.0 $11309.0 $10581.0
Inventories $7878.0 $7495.0 $6285.0
Other Income Assets $15889.0 $12401.0 $12908.0
Asset Summary
Total Current Assets $56407.0 $46116.0 $54316.0
Net Fixed Assets $16710.0 $16097.0 $14739.0
Other Noncurrent Assets $59566.0 $59134.0 $44589.0
Total Assets $132683.0 $121347.0 $113644.0
Liabilities (mil) 2013 2012 2011
Current Liabilities
Accounts Payable $6266.0 $5831.0 $5725.0
Short Term Debt $4852.0 $4676.0 $6658.0
Other Current Liabilities $14557.0 $13755.0 $10428.0
Liability Summary
Total Current Liabilities $25675.0 $24262.0 $22811.0
Long Term Debt $13328.0 $11489.0 $12969.0
Other Noncurrent Liabilities $19627.0 $20770.0 $20784.0
Total Liabilities $58630.0 $56521.0 $56564.0
Stakeholder's Equity (mil) 2013 2012 2011
Equity
Preferred Stock Equity $0.0 $0.0 $0.0
Common Stock Equity $74053.0 $64826.0 $57080.0
Equity Summary
Total Equity $74053.0 $64826.0 $57080.0
Shares Outstanding 2820.63 2778.49 2730.85

Credit Rating

Low
These businesses have a low projected risk of delinquency and a moderate to low risk of failure.

Need to go deeper? No problem.

  • Save time with complex financial data at your fingertips
  • Access financial statements, SEC filings, earnings estimates, and more
  • Call (866) 473-3932 to talk to a Business Information Consultant